BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34007176)

  • 1. Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice.
    Tan Y; Yang S; Ma Y; Li J; Xie Q; Liu C; Zhao Y
    Int J Nanomedicine; 2021; 16():3241-3254. PubMed ID: 34007176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma.
    Chen Y; Luo X; Liu Y; Zou Y; Yang S; Liu C; Zhao Y
    Int J Nanomedicine; 2022; 17():3989-4008. PubMed ID: 36105615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobubbles containing PD-L1 Ab and miR-424 mediated PD-L1 blockade, and its expression inhibition to enable and potentiate hepatocellular carcinoma immunotherapy in mice.
    Liu Y; Xie Q; Ma Y; Lin C; Li J; Hu B; Liu C; Zhao Y
    Int J Pharm; 2022 Dec; 629():122352. PubMed ID: 36374798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.
    Lin X; Huang R; Huang Y; Wang K; Li H; Bao Y; Wu C; Zhang Y; Tian X; Wang X
    Int J Nanomedicine; 2021; 16():1889-1899. PubMed ID: 33707944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobubble-mediated co-delivery of Ce6 and miR-195 for synergized sonodynamic and checkpoint blockade combination therapy with elicitation of robust immune response in hepatocellular carcinoma.
    Ma Y; Li J; Zhao Y; Hu B; Liu Y; Liu C
    Eur J Pharm Biopharm; 2022 Dec; 181():36-48. PubMed ID: 36307001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Ultrasound Nanobubbles Therapy for Prostate Cancer via Immuno-Sonodynamic Effect.
    Huang X; Chen Y; Zhong F; Gui B; Hu Y; Guo Y; Deng Q; Zhou Q
    Int J Nanomedicine; 2024; 19():2793-2806. PubMed ID: 38525011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study of a novel sonosensitizer chlorin-e6 and its sonodynamic anti-cancer activity in hepatoma-22 tumor-bearing mice.
    Shi H; Liu Q; Qin X; Wang P; Wang X
    Biopharm Drug Dispos; 2011 Sep; 32(6):319-32. PubMed ID: 21815170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer.
    Xu P; Yao J; Li Z; Wang M; Zhou L; Zhong G; Zheng Y; Li N; Zhai Z; Yang S; Wu Y; Zhang D; Dai Z
    Int J Nanomedicine; 2020; 15():2659-2668. PubMed ID: 32368047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanobubble-based anti-hepatocellular carcinoma therapy combining immune check inhibitors and sonodynamic therapy.
    Liu Y; Yang S; Zhou Q; Zhou J; Li J; Ma Y; Hu B; Liu C; Zhao Y
    Nanoscale Adv; 2022 Nov; 4(22):4847-4862. PubMed ID: 36545394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
    Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
    J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstructed adeno-associated virus with the extracellular domain of murine PD-1 induces antitumor immunity.
    Elhag OA; Hu XJ; Wen-Ying Z; Li X; Yuan YZ; Deng LF; Liu DL; Liu YL; Hui G
    Asian Pac J Cancer Prev; 2012; 13(8):4031-6. PubMed ID: 23098512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulation of Mitophagy by "All-in-One" nanosensitizer augments sonodynamic glioma therapy.
    Qu F; Wang P; Zhang K; Shi Y; Li Y; Li C; Lu J; Liu Q; Wang X
    Autophagy; 2020 Aug; 16(8):1413-1435. PubMed ID: 31674265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble PD-1 facilitates 4-1BBL-triggered antitumor immunity against murine H22 hepatocarcinoma in vivo.
    Xiao H; Huang B; Yuan Y; Li D; Han LF; Liu Y; Gong W; Wu FH; Zhang GM; Feng ZH
    Clin Cancer Res; 2007 Mar; 13(6):1823-30. PubMed ID: 17325342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation on the effects of soluble programmed death-1 (sPD-1) enhancing anti-tumor immune response.
    Yuan Y; He Y; Wang X; Zhang H; Li D; Feng Z; Zhang G
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(6):531-4. PubMed ID: 15791831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron oxide nanoparticles as nanocarriers to improve chlorin e6-based sonosensitivity in sonodynamic therapy.
    Zhang P; Ren Z; Chen Z; Zhu J; Liang J; Liao R; Wen J
    Drug Des Devel Ther; 2018; 12():4207-4216. PubMed ID: 30573951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorin e6-loaded sonosensitive magnetic nanoliposomes conjugated with the magnetic field for enhancing anti-tumor effect of sonodynamic therapy.
    Zhu HM; He Y; Huang SS; Tian JJ; Wang LS; Hao JD; Xie B; Ling JJ
    Pharm Dev Technol; 2020 Dec; 25(10):1249-1259. PubMed ID: 32811263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
    Xing R; Gao J; Cui Q; Wang Q
    Front Immunol; 2021; 12():783236. PubMed ID: 34899747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of three commercial photosensitizers for efficiency of inducing immunogenic cell death in anti-tumor immunotherapy].
    Lin X; Mao D; Bai R
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1791-1798. PubMed ID: 36651246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretion of human soluble programmed cell death protein 1 by chimeric antigen receptor-modified T cells enhances anti-tumor efficacy.
    Zhang A; Sun Y; Wang S; Du J; Gao X; Yuan Y; Zhao L; Yang Y; Xu L; Lei Y; Duan L; Xu C; Ma L; Wang J; Hu G; Chen H; Wang Q; Hu L; Zhang B
    Cytotherapy; 2020 Dec; 22(12):734-743. PubMed ID: 32684339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Sensitive Carbon Dots for Enhancing Photomediated Antitumor Immunity.
    Kim DH; Seo J; Na K
    Mol Pharm; 2020 Jul; 17(7):2532-2545. PubMed ID: 32407125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.